Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia

NCT04158752 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Trigeminal Neuralgia
Glossopharyngeal Neuralgia

Interventions

DRUG: Galcanezumab

Sponsor

Duke University

Collaborators

[object Object]